Drug Patent Expirations in July 2011

Drug Patent Expirations in July 2011

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
ALAMAST Santen pemirolast potassium 5,034,230*PED Jul 2, 2011
ANZEMET Sanofi Aventis Us dolasetron mesylate 4,906,755 Jul 2, 2011
ISTODAX Celgene romidepsin 4,977,138 Jul 6, 2011
VISIPAQUE 320 Ge Healthcare iodixanol RE36418 Jul 12, 2011
VISIPAQUE 270 Ge Healthcare iodixanol RE36418 Jul 12, 2011
MESNEX Baxter Hlthcare mesna 5,262,169 Jul 16, 2011
MESNEX Baxter Hlthcare mesna 5,252,341 Jul 16, 2011
UROXATRAL Sanofi Aventis Us alfuzosin hydrochloride 4,661,491*PED Jul 18, 2011
EQUETRO Validus Pharms Inc carbamazepine 5,326,570 Jul 23, 2011
CARBATROL Shire carbamazepine 5,326,570 Jul 23, 2011
RAPAMUNE Wyeth Pharms Inc sirolimus 5,145,684*PED Jul 25, 2011
DENTIPATCH Noven lidocaine 5,332,576 Jul 26, 2011
MULTAQ Sanofi Aventis Us dronedarone hydrochloride 5,223,510 Jul 26, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com


Leave a Reply